State Street’s ProQR Therapeutics PRQR Stock Holding History

State Street’s Portfolio PRQR Stock Details PRQR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-52,123	Closed	-$41K	–	4948
2022 Q2	$41K	Sell	52,123 -146,534	-74%	-$109K	﹤0.01%	4758
2022 Q1	$180K	Buy	198,657 +7,670	+4%	+$25.7K	﹤0.01%	4421
2021 Q4	$1.53M	Buy	190,987 +92,914	+95%	+$708K	﹤0.01%	3720
2021 Q3	$821K	Buy	98,073 +24,800	+34%	+$162K	﹤0.01%	3826
2021 Q2	$494K	Buy	+73,273	New	+$472K	﹤0.01%	3859
2020 Q4	–	Sell	-10,085	Closed	-$48K	–	3902
2020 Q3	$48K	Sell	10,085 -401	-4%	-$2.1K	﹤0.01%	3756
2020 Q2	$64K	Sell	10,486 -540	-5%	-$2.92K	﹤0.01%	3694
2020 Q1	$61K	Sell	11,026 -798	-7%	-$6.12K	﹤0.01%	3646
2019 Q4	$117K	Sell	11,824 -112,046	-90%	-$873K	﹤0.01%	3673
2019 Q3	$713K	Buy	123,870 +14,610	+13%	+$117K	﹤0.01%	3458
2019 Q2	$994K	Sell	109,260 -4,118	-4%	-$48.6K	﹤0.01%	3422
2019 Q1	$1.57M	Buy	113,378 +70,455	+164%	+$1.05M	﹤0.01%	3235
2018 Q4	$677K	Buy	+42,923	New	+$788K	﹤0.01%	3399

Other funds holding PRQR

PFM

Privium Fund Management Amsterdam, Netherlands $480M AUM 77.45% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

Opaleye Management Boston, Massachusetts $759M AUM 124.8% 1-Year Est. Return

Prosight Management Dallas, Texas $610M AUM 40.86% 1-Year Est. Return

MCM

M28 Capital Management Stamford, Connecticut $53.8M AUM 28.63% 1-Year Est. Return

MAM

Monaco Asset Management Monaco $542M AUM 54.4% 1-Year Est. Return

Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return

DCM

DAFNA Capital Management Los Angeles, California $440M AUM 109.12% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

State Street's PRQR Position: Q3 2022 in Review

State Street sold out of ProQR Therapeutics (PRQR) in Q3 2022, closing a stake of 52,123 shares — an estimated $41K sold.

State Street first reported a position in PRQR in Q4 2018 and held it in 13 quarters. The position peaked at $1.57M in Q1 2019. 47 funds tracked by Wall St. Rank hold PRQR as of Q3 2022.

State Street reported no remaining ProQR Therapeutics position as of Q3 2022 after selling out during the quarter.
State Street sold 52,123 ProQR Therapeutics shares in Q3 2022, an estimated $41K.
State Street first reported a position in ProQR Therapeutics in Q4 2018 and held it in 13 quarters.
State Street's ProQR Therapeutics position peaked at $1.57M in Q1 2019.
47 funds tracked by Wall St. Rank held ProQR Therapeutics as of Q3 2022.

Based on State Street's 13F filing for Q3 2022, filed 15 Nov 2022.